During the past decade, Saint John Macomb-Oakland Hospital conducted 161 clinical trials. In the 10-year time frame, 161 clinical trials started and 258 clinical trials were completed, i.e. on average, 160.2% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 96 clinical trials were completed. i.e. 139.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint John Macomb-Oakland Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 169 trials, followed by "Alliance for Clinical Trials in Oncology" with 107 trials sponsored, "SWOG Cancer Research Network" with 83 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored and "Radiation Therapy Oncology Group" with 25 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint John Macomb-Oakland Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 296 trials as a collaborator, "NRG Oncology" with 52 trials as a collaborator, "Cancer and Leukemia Group B" with 17 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator and "SWOG Cancer Research Network" with 13 trials as a collaborator. Other collaborators include 98 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Saint John Macomb-Oakland Hospital" are "Breast Cancer" (50 trials), "Lung Cancer" (33 trials), "Prostate Cancer" (16 trials), "Lymphoma" (15 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials). Many other conditions were trialed in "Saint John Macomb-Oakland Hospital" in a lesser frequency.

Most popular intervention types in "Saint John Macomb-Oakland Hospital" are "Drug" (378 trials), "Other" (245 trials), "Biological" (162 trials), "Procedure" (81 trials) and "Radiation" (76 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (104 trials), "Quality-of-Life Assessment" (76 trials), "Paclitaxel" (42 trials), "Questionnaire Administration" (42 trials) and "Carboplatin" (39 trials). Other intervention names were less common.

The vast majority of trials in "Saint John Macomb-Oakland Hospital" are 367 trials for "All" genders, 90 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "Saint John Macomb-Oakland Hospital". undefined are not yet recruiting, 63 are recruiting, 139 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 229 completed trials in Saint John Macomb-Oakland Hospital, 6 suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Saint John Macomb-Oakland Hospital, 16 "Phase 1" clinical trials were conducted, 238 "Phase 2" clinical trials and 217 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".